293 related articles for article (PubMed ID: 10862157)
1. Risk factors for emergence of Stenotrophomonas maltophilia in cystic fibrosis.
Talmaciu I; Varlotta L; Mortensen J; Schidlow DV
Pediatr Pulmonol; 2000 Jul; 30(1):10-5. PubMed ID: 10862157
[TBL] [Abstract][Full Text] [Related]
2. Case-control study of Stenotrophomonas maltophilia acquisition in cystic fibrosis patients.
Marchac V; Equi A; Le Bihan-Benjamin C; Hodson M; Bush A
Eur Respir J; 2004 Jan; 23(1):98-102. PubMed ID: 14738239
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting the incidence of Stenotrophomonas maltophilia isolation in cystic fibrosis.
Graff GR; Burns JL
Chest; 2002 Jun; 121(6):1754-60. PubMed ID: 12065335
[TBL] [Abstract][Full Text] [Related]
4. Stenotrophomonas maltophilia: A marker of lung disease severity.
Berdah L; Taytard J; Leyronnas S; Clement A; Boelle PY; Corvol H
Pediatr Pulmonol; 2018 Apr; 53(4):426-430. PubMed ID: 29314745
[TBL] [Abstract][Full Text] [Related]
5. Cystic fibrosis related diabetes is not independently associated with increased Stenotrophomonas maltophilia infection: Longitudinal data from the UK CF Registry.
Frost F; Nazareth D; Shaw M; Walshaw MJ
J Cyst Fibros; 2019 Mar; 18(2):294-298. PubMed ID: 30741162
[TBL] [Abstract][Full Text] [Related]
6.
Willsey GG; Eckstrom K; LaBauve AE; Hinkel LA; Schutz K; Meagher RJ; LiPuma JJ; Wargo MJ
J Bacteriol; 2019 Aug; 201(15):. PubMed ID: 31109991
[No Abstract] [Full Text] [Related]
7. Characterization of small-colony-variant Stenotrophomonas maltophilia isolated from the sputum specimens of five patients with cystic fibrosis.
Anderson SW; Stapp JR; Burns JL; Qin X
J Clin Microbiol; 2007 Feb; 45(2):529-35. PubMed ID: 17135443
[TBL] [Abstract][Full Text] [Related]
8. Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease.
Waters V; Yau Y; Prasad S; Lu A; Atenafu E; Crandall I; Tom S; Tullis E; Ratjen F
Am J Respir Crit Care Med; 2011 Mar; 183(5):635-40. PubMed ID: 20889901
[TBL] [Abstract][Full Text] [Related]
9. Adaptation of Stenotrophomonas maltophilia in cystic fibrosis: molecular diversity, mutation frequency and antibiotic resistance.
Vidigal PG; Dittmer S; Steinmann E; Buer J; Rath PM; Steinmann J
Int J Med Microbiol; 2014 Jul; 304(5-6):613-9. PubMed ID: 24836944
[TBL] [Abstract][Full Text] [Related]
10. Investigation of Stenotrophomonas maltophilia epidemiology in a French cystic fibrosis center.
Capaldo C; Beauruelle C; Saliou P; Rault G; Ramel S; Héry-Arnaud G
Respir Med Res; 2020 Nov; 78():100757. PubMed ID: 32759054
[TBL] [Abstract][Full Text] [Related]
11. Cystic Fibrosis-Associated Stenotrophomonas maltophilia Strain-Specific Adaptations and Responses to pH.
Gallagher T; Phan J; Oliver A; Chase AB; England WE; Wandro S; Hendrickson C; Riedel SF; Whiteson K
J Bacteriol; 2019 Apr; 201(7):. PubMed ID: 30642989
[TBL] [Abstract][Full Text] [Related]
12. Association between glucose intolerance and bacterial colonisation in an adult population with cystic fibrosis, emergence of Stenotrophomonas maltophilia.
Lehoux Dubois C; Boudreau V; Tremblay F; Lavoie A; Berthiaume Y; Rabasa-Lhoret R; Coriati A
J Cyst Fibros; 2017 May; 16(3):418-424. PubMed ID: 28284526
[TBL] [Abstract][Full Text] [Related]
13. Significance of positive Stenotrophomonas maltophilia culture in acute respiratory tract infection.
Pathmanathan A; Waterer GW
Eur Respir J; 2005 May; 25(5):911-4. PubMed ID: 15863651
[TBL] [Abstract][Full Text] [Related]
14. Denitrification by cystic fibrosis pathogens - Stenotrophomonas maltophilia is dormant in sputum.
Kolpen M; Kragh KN; Bjarnsholt T; Line L; Hansen CR; Dalbøge CS; Hansen N; Kühl M; Høiby N; Jensen PØ
Int J Med Microbiol; 2015 Jan; 305(1):1-10. PubMed ID: 25441256
[TBL] [Abstract][Full Text] [Related]
15. Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis.
Goss CH; Otto K; Aitken ML; Rubenfeld GD
Am J Respir Crit Care Med; 2002 Aug; 166(3):356-61. PubMed ID: 12153970
[TBL] [Abstract][Full Text] [Related]
16.
Alcaraz E; Centrón D; Camicia G; Quiroga MP; Di Conza J; Passerini de Rossi B
J Med Microbiol; 2021 Jan; 70(1):. PubMed ID: 33258754
[No Abstract] [Full Text] [Related]
17. Air pollution exposure is associated with MRSA acquisition in young U.S. children with cystic fibrosis.
Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
BMC Pulm Med; 2017 Jul; 17(1):106. PubMed ID: 28750627
[TBL] [Abstract][Full Text] [Related]
18. Biofilm compared to conventional antimicrobial susceptibility of Stenotrophomonas maltophilia Isolates from cystic fibrosis patients.
Wu K; Yau YC; Matukas L; Waters V
Antimicrob Agents Chemother; 2013 Mar; 57(3):1546-8. PubMed ID: 23295930
[TBL] [Abstract][Full Text] [Related]
19. Molecular Characterization of Stenotrophomonas maltophilia isolates from cystic fibrosis patients and the hospital environment.
Marzuillo C; De Giusti M; Tufi D; Giordano A; Del Cimmuto A; Quattrucci S; Mancini C; Villari P
Infect Control Hosp Epidemiol; 2009 Aug; 30(8):753-8. PubMed ID: 19583515
[TBL] [Abstract][Full Text] [Related]
20. Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis.
Krzewinski JW; Nguyen CD; Foster JM; Burns JL
J Clin Microbiol; 2001 Oct; 39(10):3597-602. PubMed ID: 11574579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
